Comerica Bank increased its stake in shares of LHC Group, Inc. (NASDAQ:LHCG) by 1.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 29,759 shares of the health services provider’s stock after buying an additional 336 shares during the period. Comerica Bank’s holdings in LHC Group were worth $3,172,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds also recently added to or reduced their stakes in LHCG. FMR LLC boosted its holdings in LHC Group by 297.8% during the second quarter. FMR LLC now owns 1,151,406 shares of the health services provider’s stock worth $98,548,000 after buying an additional 861,952 shares in the last quarter. Bank of New York Mellon Corp raised its position in LHC Group by 162.0% during the second quarter. Bank of New York Mellon Corp now owns 711,508 shares of the health services provider’s stock worth $60,897,000 after acquiring an additional 439,947 shares during the last quarter. American Century Companies Inc. acquired a new position in LHC Group during the third quarter worth about $35,964,000. GW&K Investment Management LLC acquired a new position in LHC Group during the third quarter worth about $24,836,000. Finally, Redmile Group LLC acquired a new position in LHC Group during the third quarter worth about $22,398,000. 88.57% of the stock is currently owned by hedge funds and other institutional investors.
NASDAQ:LHCG opened at $109.69 on Friday. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.17. The company has a market capitalization of $3.34 billion, a PE ratio of 45.33, a PEG ratio of 1.57 and a beta of 0.89. LHC Group, Inc. has a 1-year low of $59.21 and a 1-year high of $114.22.
LHC Group (NASDAQ:LHCG) last posted its quarterly earnings data on Wednesday, February 27th. The health services provider reported $1.03 earnings per share for the quarter, beating analysts’ consensus estimates of $1.02 by $0.01. The business had revenue of $509.80 million during the quarter, compared to analyst estimates of $522.21 million. LHC Group had a net margin of 3.85% and a return on equity of 8.23%. The company’s revenue was up 75.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.62 earnings per share. Research analysts anticipate that LHC Group, Inc. will post 3.53 earnings per share for the current fiscal year.
A number of equities analysts have issued reports on the stock. BidaskClub cut shares of LHC Group from a “strong-buy” rating to a “buy” rating in a research report on Thursday. Zacks Investment Research upgraded shares of LHC Group from a “hold” rating to a “buy” rating and set a $105.00 target price for the company in a research report on Wednesday, January 2nd. Barclays assumed coverage on shares of LHC Group in a research report on Friday, December 14th. They set an “equal weight” rating and a $105.00 target price for the company. UBS Group assumed coverage on shares of LHC Group in a research report on Thursday, November 15th. They set a “buy” rating and a $109.00 target price for the company. Finally, Robert W. Baird lifted their target price on shares of LHC Group from $95.00 to $98.00 and gave the stock a “neutral” rating in a research report on Friday, November 2nd. Four analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. LHC Group presently has an average rating of “Buy” and an average target price of $105.77.
In other news, SVP Jeff Reibel sold 5,239 shares of the business’s stock in a transaction that occurred on Tuesday, December 4th. The shares were sold at an average price of $105.26, for a total value of $551,457.14. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Keith G. Myers sold 75,000 shares of the business’s stock in a transaction that occurred on Monday, December 3rd. The shares were sold at an average price of $103.40, for a total transaction of $7,755,000.00. The disclosure for this sale can be found here. In the last three months, insiders sold 241,821 shares of company stock valued at $24,422,790. Company insiders own 6.80% of the company’s stock.
LHC Group Profile
LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.
Featured Story: P/E Growth (PEG)
Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group, Inc. (NASDAQ:LHCG).
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.